The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows
It was little more than a month ago when the Biden Administration unleashed its draft guidelines for applying the march-in provisions of the Bayh-Dole Act.
Source: ipwatchdog.com